EconPapers    
Economics at your fingertips  
 

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

Gayatri Amirthalingam (), Jamie Lopez Bernal, Nick J. Andrews, Heather Whitaker, Charlotte Gower, Julia Stowe, Elise Tessier, Sathyavani Subbarao, Georgina Ireland, Frances Baawuah, Ezra Linley, Lenesha Warrener, Michelle O’Brien, Corinne Whillock, Paul Moss, Shamez N. Ladhani, Kevin E. Brown and Mary E. Ramsay
Additional contact information
Gayatri Amirthalingam: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Jamie Lopez Bernal: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Nick J. Andrews: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Heather Whitaker: Statistics, Modelling and Economics Department, UK Health Security Agency
Charlotte Gower: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Julia Stowe: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Elise Tessier: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Sathyavani Subbarao: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Georgina Ireland: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Frances Baawuah: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Ezra Linley: Sero-Epidemiolgy Unit, UK Health Security Agency
Lenesha Warrener: Virus Reference Department, UK Health Security Agency
Michelle O’Brien: Brondesbury Medical Centre, Kilburn
Corinne Whillock: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Paul Moss: University of Birmingham
Shamez N. Ladhani: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Kevin E. Brown: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency
Mary E. Ramsay: Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency

Nature Communications, 2022, vol. 13, issue 1, 1-1

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-022-28393-7 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28393-7

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-28393-7

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28393-7